Psoriasis Vulgaris: An Evidence-Based Guide for Primary Care

Kupetsky, Erine A.; Keller, Matthew

doi:10.3122/jabfm.2013.06.130055

Cited by 29 publications

(18 citation statements)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Disease severity is graded by the patient's body surface area which has plaque involvement. Significant involvement of the palms/soles, face, and intertriginous areas may be especially debilitating (2). The literature suggests about 25% of PsO patients experience moderate to severe disease (5).…”

Section: Introductionmentioning

confidence: 99%

“…Treatment is focused on the use of anti-inflammatory agents to control disease symptoms (1)(2)(3). Disease severity is graded by the patient's body surface area which has plaque involvement.…”

Section: Introductionmentioning

confidence: 99%

“…This disorder has numerous pathological pathways, which may be associated with comorbidities such as metabolic disorder, cardiovascular disease, and other sequelae of chronic inflammation, such as inflammatory bowel disorder and arthritis (1)(2)(3). PsO prevalence estimates among adults in the United States range from 2.2% to 3.2% (4,5).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis

Goren

Carter

Lee

2015

Journal of Dermatological Treatment

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis

Goren

Carter

Lee

2015

Journal of Dermatological Treatment

View full text Add to dashboard Cite

show abstract

“…1 It is a disease with a high burden and substantial impact on quality of life. Since there are no biomarkers available to assess disease severity, clinical assessment tools are used to measure the disease severity and treatment response in clinical trials and daily practice.…”

mentioning

confidence: 99%

The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment

Bożek¹,

Reich²

2017

Adv Clin Exp Med

103

View full text Add to dashboard Cite

show abstract

“…Uncommon, but treatable-let's find and treat them! Kupetsky et al 16 provide a useful review of diagnosing and treating psoriasis for primary care clinicians. Wahlert 19 revealed that most academic family physicians have experience treating failure of early pregnancy, often with medications, but a minority have provided abortions during early pregnancy.…”

Section: Care Of Patients With Specific Health Issuesmentioning

confidence: 99%

Family Physicians Improve Patient Health Care Quality and Outcomes

Bowman¹,

Neale²

2013

The Journal of the American Board of Family Medicine

View full text Add to dashboard Cite

This issue exemplifies family physicians' ability to provide great care and to continuously improve. For example, beyond other specialty care, the care provided by family physicians is associated with improved melanoma diagnosis and outcomes and improved preventive services for those with a history of breast cancer. Electronic health records are providing new avenues to both assess outcomes and influence care. However, to truly reward quality care, simplistic and readily measurable items such as laboratory results or assessment of the provision of preventive services must be adjusted for risk. Health insurance influences classic preventive care services more than personal health behaviors. The care provided at federally qualified health centers throughout the nation is highly appreciated by the people they serve and is not plagued by the types of disparities in other settings. (J Am Board Fam Med 2013; 26:617-619.)Maly et al 1 show the positive impact of family physicians on recommended preventive services in the follow-up care of underserved female breast cancer survivors. The disparity between specialities was dramatic for colonoscopy in particular, where only a quarter of patients seeing only surgeons/ cancer specialists for follow-up received the recommended screening.Related to another cancer-melanoma-Roetzheim et al 2 showed that visiting a family physician compared with only a dermatologist before the diagnosis of melanoma was associated with a diagnosis of more thin melanomas and possibly a lower rate of mortality. To improve the accuracy of detection of skin cancers, Eide et al 3 tested an intriguing intervention using a readily available, 1-to 2-hour, interactive web-based course. In addition to evaluations after the course, this study considered referrals to dermatology before and after the course and diagnoses after the course. Most of the providers had trained in internal medicine. The evaluations immediately and after 6 months found improved scores, and the later practice patterns found fewer referrals to dermatology but no obvious change in the rate of diagnosis of skin cancers. The physicians reporting no past dermatology training had the greatest improvement. Effects of Insurance on Preventive Services and Health BehaviorsJerant et al 4 reported that patients who newly obtained health insurance after being uninsured clearly receive more recommended preventive care that are based on the health system (eg, Papanicolaou tests, mammograms, and immunizations); the opposite is also true: losing insurance decreases these services. Yet patients' personal health behaviors did not improve or worsen with changes in health insurance. Unfortunately, this questions the ability of the health care system to either recognize negative patient behaviors, assist patients in changing them, or both. Perhaps follow-up longer than 1 year would change these outcomes since behavior changes often take repeated efforts over multiple years.

show abstract

Psoriasis Vulgaris: An Evidence-Based Guide for Primary Care

Cited by 29 publications

References 70 publications

Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis

Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis

The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment

Family Physicians Improve Patient Health Care Quality and Outcomes

Contact Info

Product

Resources

About